Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

10X Genomics Inc (10X Genomics) is a life science technology company that develops innovative genomics platforms. It offers a chromium single cell platform which includes microfluidic chips, consumables, and the Chromium X Series and legacy chromium instruments for single-cell analysis, enabling researchers to perform transcriptomic profiling and multiomic studies to understand human disorders. 10X Genomics offers a Visium Spatial platform, designed for spatial gene expression analysis. It also offers Xenium In Situ, targets in tissue sections with single cell spatial imaging. It serves academic and translational researchers and biopharmaceutical companies. The company operates in the North America, Asia, and Europe. 10X Genomics is headquartered in Pleasanton, California, the US.

Gain a 360-degree view of 10X Genomics Inc and make more informed decisions for your business Gain a 360-degree view of 10X Genomics Inc and make more informed decisions for your business Register your interest
Headquarters United States of America

Address 6230 Stoneridge Mall Road, Pleasanton, California, 94588-3260


Telephone 1 925 4017300

No of Employees 1,178

Industry Medical Equipment

Ticker Symbol & Exchange TXG (NASD)

Revenue (2024) $642.8M 5.2% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ 76.2% (2024 vs 2023)

Market Cap* $5.0B

Net Profit Margin (2024) XYZ 77.4% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Products and Services

Products Services
Platform: Technical Assistance and Training
Chromium Single Cell:
Universal 3' Gene Expression
XYZ
XYZ
XYZ
Understand 10X Genomics Inc portfolio and identify potential areas for collaboration Understand 10X Genomics Inc portfolio and identify potential areas for collaboration Register your interest

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 Acquisitions/Mergers/Takeovers In June, the company acquired the Proteintech Genomics division from Proteintech Group.
2026 New Products/Services In April, the company launched Atera, a new in situ spatial biology platform.
2026 Contracts/Agreements In January, the company partnered with CareDx Inc. to launch ImmuneScape, a multiomics research initiative.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Register your interest
Image for loader

Competitor Comparison

Key Parameters 10X Genomics Inc Illumina Inc Standard BioTools Inc Akoya Biosciences Inc Parse Biosciences Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Pleasanton San Diego Boston Marlborough Seattle
State/Province California California Massachusetts Massachusetts Washington
No. of Employees 1,178 8,600 385 205 -
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
John R. Stuelpnagel Chairman Executive Board 2013 68
Serge Saxonov, Ph.D. Chief Executive Officer; Director Executive Board 2012 49
Benjamin J. Hindson, Ph.D. Director; Chief Scientific Officer; President Executive Board 2012 51
Adam S. Taich Chief Financial Officer Senior Management 2024 51
Michael Schnall-Levin Chief Strategy Officer; Chief Technology Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into 10X Genomics Inc key executives to enhance your sales strategy Gain insight into 10X Genomics Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?